Afraid of pharma pushback, a health data broker puts up a barrier to drug pricing information

1 December 2022 - At a time when many Americans are clamouring for more transparency into prescription drug pricing, one ...

Read more →

How CSL priced the world’s most expensive drug

1 December 2022 - When blood products giant CSL announced last week it had been given US regulatory approval for ...

Read more →

Korea to add Canada, Australia to drug pricing reference country list

24 November 2022 - The Government said it would additionally reference Canada and Australia when setting drug prices from January ...

Read more →

Bristol Myers Squibb warns US price reforms will dent drug development

20 November 2022 - Biggest shake-up in pharma pricing in decades prompts companies to shelve some potential therapies. ...

Read more →

Big pharma may have to reveal government deals in WHO's draft pandemic rules

17 November 2022 - Pharmaceutical companies could be made to disclose prices and deals agreed for any products they make ...

Read more →

Getting the price right: lessons for Medicare price negotiation from peer countries

9 November 2022 - The US pays more for brand-name prescription drugs than any other country and new legislation from August ...

Read more →

Inflation Reduction Act drug pricing provisions aren’t at all like price controls in Europe

18 November 2022 - The opposition to the prescription drug pricing provisions in the Inflation Reduction Act can be hyperbolic.  ...

Read more →

A tussle over medicines pricing is looming in Britain

15 November 2022 - Agreement to limit the size of the NHS drugs bill under strain. ...

Read more →

EQRx no longer seeks to disrupt prices in non-small-cell lung cancer space

10 November 2022 - The biotechnology company EQRx no longer seeks to disrupt prices in the non-small-cell lung cancer space. ...

Read more →

Implementation of the Patented Medicine Prices Review Board's proposed Guidelines will harm Canadian patients

10 November 2022 - Innovative Medicines Canada is calling on Health Canada to direct the Patented Medicine Prices Review Board (PMPRB) ...

Read more →

New PMPRB guidelines proposed for assessing prices of patented medicines sold in Canada

4 November 2022 - Controversial amendments to the Patented Medicines Regulations changing the basket of comparator countries considered by the ...

Read more →

New US cancer drug prices rise 53% in five years

2 November 2022 - The annual price of a newly-launched cancer drug in the United States averaged $283,000 last year, ...

Read more →

Association between US drug price and measures of efficacy for oncology drugs approved by the US FDA from 2015 to 2020

31 October 2022 - The past five years have seen a marked increase in the number of cancer therapies on the ...

Read more →

Another example of a “Shkrelian” drug price increase

28 October 2022 - The story of Martin Shkreli and the drug, Daraprim, has been used as an example of drug ...

Read more →

Drug maker raises the price of an old chemo medicine tenfold amid persistent shortages

27 October 2022 - Amid sporadic shortages of a drug that is essential in preparing patients for lifesaving, cancer-fighting treatments, ...

Read more →